Stay updated on Galunisertib with Nivolumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Galunisertib with Nivolumab in Solid Tumors Clinical Trial page.

Latest updates to the Galunisertib with Nivolumab in Solid Tumors Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision tag updated from v3.6.5 to v3.6.6, indicating a page version update; the change appears to affect only the revision label and not the study content or core functionality.SummaryDifference0.0%

- Check17 days agoChange DetectedA new NIH grant/contract tag was added to the study's identifiers, indicating NIH funding support for this trial. This addition helps identify the source of funding in the study metadata.SummaryDifference0.0%

- Check31 days agoChange DetectedThe page’s revision tag was updated to v3.6.5 from v3.6.4, indicating a small template update rather than a change to study information or user actions.SummaryDifference0.0%

- Check52 days agoChange DetectedA new revision tag v3.6.4 appears on the page, replacing the previous v3.6.3 to reflect a minor site update.SummaryDifference0.0%

- Check73 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.3. This indicates a newer release of the page template or rendering tooling used to present the study record.SummaryDifference0.0%

- Check88 days agoChange DetectedRecruitment status updated to no longer recruit; new help sections were added (How to Read a Study Record, Common Questions, How to Join a Study), the Intervention/Treatment label was standardized, and the page revision tag was updated to v3.6.0.SummaryDifference0.4%

Stay in the know with updates to Galunisertib with Nivolumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Galunisertib with Nivolumab in Solid Tumors Clinical Trial page.